UK markets closed

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.7700-0.1700 (-4.31%)
At close: 04:00PM EDT
3.9100 +0.14 (+3.71%)
After hours: 06:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
24,406
29,459
47,306
44,937
24,681
Selling general and administrative
10,978
13,335
15,374
11,283
9,985
Total operating expenses
35,385
42,794
62,680
56,220
34,667
Operating income or loss
-35,385
-42,794
-62,680
-56,220
-34,667
Interest expense
2,079
2,071
1,694
1,742
1,904
Total other income/expenses net
-
-
-
-
-1,754
Income before tax
-30,009
-37,543
-62,025
-57,776
-38,033
Income tax expense
-
-
-
0
-479.265
Income from continuing operations
-30,009
-37,543
-62,025
-57,776
-37,554
Net income
-30,009
-37,543
-62,025
-57,776
-37,554
Net income available to common shareholders
-30,009
-37,543
-62,025
-57,776
-37,554
Basic EPS
-0.78
-0.64
-1.06
-1.07
-1.11
Diluted EPS
-0.78
-0.64
-1.06
-1.07
-1.11
Basic average shares
58,785
58,943
58,406
54,042
33,966
Diluted average shares
58,785
58,943
58,406
54,042
33,966